ZeroStack (FLGC) Company Report

On December 29, 2025, Flora Growth Corp. (FLGC) entered into a Note Settlement Agreement with DeFi Development Corp. to settle a Solana-denominated convertible note.
The settlement requires FLGC to make payments by January 6, 2026, including 96,161.907647528 Solana, US$1,750,000 in cash, and 111,550 common shares.
The 111,550 common shares are valued at US$6.90 per share, totaling US$769,695.
Upon completion of these payments, FLGC will be released from all obligations under the note, and both parties will mutually release claims related to the note and the original securities purchase agreement.
The common shares issued as part of the settlement are being made under an exemption from the registration requirements of the U.S. Securities Act.

Dec 31, 2025, 9:18 PM

Flora Growth Corp. Shareholders Approve Amended Incentive Plan and Executive Stock Option Grants

FLGC

Executive Compensation

Proxy Vote Outcomes

On December 19, 2025, Flora Growth Corp. shareholders approved an amendment to the 2022 Incentive Compensation Plan.
This amendment significantly increased the number of common shares issuable under the plan from 115,385 to 1,506,892 and incentive stock options from 21,795 to 847,843.
Following the amendment's approval, stock options were granted to the Chief Executive Officer, Chief Financial Officer, and Executive Chairman.
These options have an exercise price of $7.31 per share and vest in 20% increments as the company's volume weighted average price (VWAP) reaches $10.97, $14.62, $18.28, $21.93, and $25.59.

Dec 22, 2025, 10:03 PM

Flora Growth Corp. enters into $50 million equity purchase agreement

FLGC

New Projects/Investments

Flora Growth Corp. entered into a Common Share Purchase Agreement with White Lion Capital, LLC, effective November 28, 2025, to sell up to $25 million of its common shares, with the potential to increase to $50 million at the Company's discretion.
The agreement has a 24-month term, allowing the Company to direct the Investor to purchase shares at a price based on the market, specifically 97% of the lowest daily VWAP for regular purchases.
The Company will pay a commitment fee of $125,000 in common shares (0.5% of the initial commitment) to the Investor, with an additional $125,000 if the commitment is increased to $50 million.
Proceeds are intended to primarily advance the Company's digital asset treasury strategy with a focus on the $0G token and for general corporate purposes.
Share issuances under the agreement are subject to an Exchange Cap of 149,287 shares (19.99% of outstanding shares as of the Execution Date) unless stockholder approval is obtained or the average price paid is at least $7.54.

Nov 28, 2025, 5:58 PM

ZeroStack, a Flora Growth Corp. subsidiary, secures over $401 million in funding and launches $0G token

FLGC

New Projects/Investments

Management Change

ZeroStack, a subsidiary of Flora Growth Corp., secured over $401 million in support, comprising digital assets, token allocations, convertible notes, and a $13.66 million cash raise through the sale of FLGC shares.
The $0G token was launched on September 22, 2025, with an initial valuation of $3.00 per token. As of October 8, 2025, the token was trading at $2.78, resulting in a market capitalization of approximately $593 million.
ZeroStack successfully sold 175,500 AI Alignment Node licenses, generating $30 million.
Daniel Reis-Faria was appointed CEO and board director, and Michael Heinrich was appointed Executive Chairman and board director, with Dany Vaiman remaining as CFO.

Oct 10, 2025, 9:24 PM

Flora Growth Corp. initiates new at-the-market offering for common shares

FLGC

Flora Growth Corp. filed a prospectus supplement on September 29, 2025, to establish a new "at the market" (ATM) program.
Under this new ATM program, the company may sell up to an additional $3,450,000 of common shares.
This new offering replaces a previous prospectus supplement, under which $129,482 in common shares had been sold.

Sep 29, 2025, 9:18 PM

Flora Growth Corp. Enters At-The-Market Sales Agreement

FLGC

Flora Growth Corp. entered into an "at-the-market" sales agreement with Revere Securities LLC on September 23, 2025.
This agreement allows the company to sell common shares from time to time through Revere Securities LLC, acting as the sales agent.
The company intends to use the net proceeds for general corporate purposes.
The compensation payable to the agent is tiered: 3.00% for the first $150 million, 2.00% for the next $350 million, and 1.25% for proceeds exceeding $500 million.
Flora Growth Corp. is not obligated to make any sales under this agreement.

Sep 23, 2025, 12:28 PM

Flora Growth Corp. reports pro forma financials after cannabis business disposition and enters securities purchase agreement

FLGC

M&A

Flora Growth Corp. has released unaudited pro forma consolidated financial statements as of June 30, 2025, and for the six months ended June 30, 2025, and the year ended December 31, 2024, reflecting the disposition of its hemp and cannabis-related businesses.
The pro forma net loss for the six months ended June 30, 2025, is $(3,257) thousand, and for the year ended December 31, 2024, is $(8,985) thousand.
As of June 30, 2025, the company's pro forma total assets are $7,861 thousand, with total shareholders' equity at $(644) thousand.
On September 19, 2025, Flora Growth Corp. entered into a Securities Purchase Agreement to sell Common Shares and Warrants to investors, with shares priced at US$25.19 and prefunded warrants at US$25.1899.
A Voting Agreement was also executed, requiring shareholder approval for the issuance of these securities, a potential company name change, and a stock split.